DealBook: Dendreon, Maker of Prostate Cancer Drug Provenge, Files for Bankruptcy

Monday, November 10, 2014 - 15:20 in Mathematics & Economics

Dendreon filed for bankruptcy protection on Monday after sales of Provenge fell way short of expectations and the company could not pay off a huge debt coming due.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net